More Realistic Forecasting of Future Life Events After Psilocybin for Treatment-Resistant Depression

被引:36
|
作者
Lyons, Taylor [1 ]
Carhart-Harris, Robin Lester [1 ]
机构
[1] Imperial Coll London, Dept Med, Psychedel Res Grp, London, England
来源
FRONTIERS IN PSYCHOLOGY | 2018年 / 9卷
关键词
treatment-resistant depression; psilocybin; cognitive bias; pessimism; forecasting; LYSERGIC-ACID DIETHYLAMIDE; DEFAULT-MODE NETWORK; MYSTICAL-TYPE EXPERIENCES; 5-HT2A RECEPTOR-BINDING; DYSFUNCTIONAL ATTITUDES; SPIRITUAL SIGNIFICANCE; UNREALISTIC OPTIMISM; POSITIVE ILLUSIONS; THREATENING CANCER; HEALTHY-SUBJECTS;
D O I
10.3389/fpsyg.2018.01721
中图分类号
B84 [心理学];
学科分类号
04 ; 0402 ;
摘要
Background: Evidence suggests that classical psychedelics can promote enduring changes in personality, attitudes and optimism, as well as improvements in mental health outcomes. Aim: To investigate the effects of a composite intervention, involving psilocybin, on pessimism biases in patients with treatment-resistant depression (TRD). Methods: Patients with TRD (n = 15) and matched, untreated non-depressed controls (n = 15) performed the Prediction Of Future Life Events (POFLE) task. The POFLE task requires participants to predict the likelihood of certain life events occurring within a 30day period, after which the actual rate of event occurrence is reported; this gives an index of potential pessimism versus optimism bias. Psilocybin was administered in two oral dosing sessions (10 and 25 mg) one week apart. Main outcome measures were collected at baseline and one week after the second dosing session. Results: Patients showed a significant pessimism bias at baseline [t(14) = 3.260, p = 0.006; 95% CI (-0.16, -0.03), g = 1.1] which was related to the severity of their depressive symptoms (r(s) = 0.55, p = 0.017). One week after psilocybin treatment, this bias was significantly decreased [t(14) = 2.714, p = 0.017; 95% CI (-0.21, -0.02), g = 0.7] and depressive symptoms were greatly improved [t(14) = 7.900, p < 0.001; 95% CI (16.17, 28.23), g = 1.9]; moreover, the magnitude of change in both variables was significantly correlated (r = -0.57, p = 0.014). Importantly, post treatment, patients became significantly more accurate at predicting the occurrence of future life events [t(14) = 1.857, p = 0.042; 95% CI (-0.01, 0.12), g = 0.6] whereas no such change was observed in the control subjects. Conclusion: These findings suggest that psilocybin with psychological support might correct pessimism biases in TRD, enabling a more positive and accurate outlook.
引用
收藏
页数:11
相关论文
共 50 条
  • [41] Treatment-resistant depression
    Ananth, J
    PSYCHOTHERAPY AND PSYCHOSOMATICS, 1998, 67 (02) : 61 - 70
  • [42] TREATMENT-RESISTANT DEPRESSION
    WHITE, K
    SIMPSON, G
    PSYCHIATRIC ANNALS, 1987, 17 (04) : 274 - 278
  • [43] TREATMENT-RESISTANT DEPRESSION
    SIMPSON, GM
    KESSEL, JB
    BRITISH JOURNAL OF PSYCHIATRY, 1991, 159 : 162 - 163
  • [44] Treatment-resistant depression
    Videbech, P.
    ACTA PSYCHIATRICA SCANDINAVICA, 2013, 128 (06) : 496 - 497
  • [45] Treatment-resistant depression
    Nolen, W. A.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2007, 17 : S145 - S145
  • [46] Treatment-Resistant Depression
    Little, Alison
    AMERICAN FAMILY PHYSICIAN, 2009, 80 (02) : 167 - 172
  • [47] Psilocybin assisted psychotherapy for treatment-resistant Anorexia nervosa
    Touyz, Stephen
    Maguire, Sarah
    Griffiths, Kristi
    JOURNAL OF EATING DISORDERS, 2024, 12
  • [48] Psilocybin with psychological support for treatment-resistant depression: six-month follow-up
    Carhart-Harris, R. L.
    Bolstridge, M.
    Day, C. M. J.
    Rucker, J.
    Watts, R.
    Erritzoe, D. E.
    Kaelen, M.
    Giribaldi, B.
    Bloomfield, M.
    Pilling, S.
    Rickard, J. A.
    Forbes, B.
    Feilding, A.
    Taylor, D.
    Curran, H. V.
    Nutt, D. J.
    PSYCHOPHARMACOLOGY, 2018, 235 (02) : 399 - 408
  • [49] Development and Evaluation of a Therapist Training Program for Psilocybin Therapy for Treatment-Resistant Depression in Clinical Research
    Tai, Sara J.
    Nielson, Elizabeth M.
    Lennard-Jones, Molly
    Johanna Ajantaival, Riikka-Liisa
    Winzer, Rachel
    Richards, William A.
    Reinholdt, Frederick
    Richards, Brian D.
    Gasser, Peter
    Malievskaia, Ekaterina
    FRONTIERS IN PSYCHIATRY, 2021, 12
  • [50] On blinding and suicide risk in a recent trial of psilocybin-assisted therapy for treatment-resistant depression
    Gukasyan, Natalie
    MED, 2023, 4 (01): : 8 - 9